Molecular and clinical implications of CHD1 loss and SPOP mutations in advanced prostate cancer.

被引：1
|
作者：
Rescigno, Pasquale
Boysen, Gunther
Rodrigues, Daniel Nava
Seed, George
Dolling, David
Riisnaes, Ruth
Crespo, Mateus
Bianchini, Diletta
Sumanasuriya, Semini
Figueiredo, Ines
Christova, Rossitza
Gil, Veronica
Goodall, Jane
Sharp, Adam
Rubin, Mark A.
Yuan, Wei
Barbieri, Christopher
Mateo, Joaquin
Carreira, Suzanne
De Bono, Johann S.
机构：
[1] Inst Canc Res, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[3] Inst Canc Res, Clin Trials & Stat Unit, London, England
[4] Univ Bern, Bern, Switzerland
[5] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.5064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5064
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SPOP and CHD1 Alterations in Prostate Cancer. Relationship with PTEN Loss and Grade Group Classification
    Hernandez-Llodra, Silvia
    Segales Tana, Laura
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Lloveras, Belen
    Lloreta-Trull, Josep
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 897 - 897
  • [2] SPOP and CHD1 Alterations in Prostate Cancer. Relationship with PTEN Loss and Grade Group Classification
    Hernandez-Llodra, Silvia
    Segales Tana, Laura
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Lloveras, Belen
    Lloreta-Trull, Josep
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 897 - 897
  • [3] Coordinated roles of CHD1 and SPOP in prostate cancer pathogenesis
    Vasudevan, Divya
    Blattner, Mirjam
    Deonarine, Lesa D.
    Chen, Yu
    Rubin, Mark A.
    Barbieri, Christopher E.
    CANCER RESEARCH, 2016, 76
  • [4] CHD1 as a therapeutic target for prostate cancer.
    Wang, Y. Alan
    Zhao, Di
    Depinho, Ron
    CANCER RESEARCH, 2018, 78 (16) : 79 - 80
  • [5] SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence
    Hernandez-Llodra, Silvia
    Segales, Laura
    Juanpere, Nuria
    Lorenzo, Tech Marta
    Salido, Marta
    Nonell, Lara
    Lopez, Tech David
    Rodriguez-Vida, Alejo
    Bellmunt, Joaquim
    Fumado, Lluis
    Cecchini, Lluis
    Lloreta-Trull, Josep
    PROSTATE, 2021, 81 (16): : 1267 - 1277
  • [6] CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage
    Zhu, Yini
    Wen, Jiling
    Huang, Gang
    Mittlesteadt, Jackson
    Wen, Xiaofei
    Lu, Xin
    PROSTATE, 2021, 81 (01): : 81 - 88
  • [7] CHD1, a multifaceted epigenetic remodeler in prostate cancer
    Li, Haoyan
    Gigi, Loraine
    Zhao, Di
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Monitoring CHD1 During Prostate Cancer Progression
    Rodrigues, Daniel Nava
    Boysen, Gunther
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa Y.
    Miranda, Susana A. A.
    Figueiredo, Ines
    Gil, Veronica
    Aziz, Sara
    Mehra, Niven
    Sharp, Adam
    Rescigno, Pasquale
    Mosquera, Juan Miguel
    Barbieri, Christopher E.
    Rubin, Mark
    De Bono, Johann S.
    LABORATORY INVESTIGATION, 2016, 96 : 251A - 251A
  • [9] Monitoring CHD1 During Prostate Cancer Progression
    Rodrigues, Daniel Nava
    Boysen, Gunther
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa Y.
    Miranda, Susana A. A.
    Figueiredo, Ines
    Gil, Veronica
    Aziz, Sara
    Mehra, Niven
    Sharp, Adam
    Rescigno, Pasquale
    Mosquera, Juan Miguel
    Barbieri, Christopher E.
    Rubin, Mark
    De Bono, Johann S.
    MODERN PATHOLOGY, 2016, 29 : 251A - 251A
  • [10] Monitoring CHD1 during prostate cancer progression
    Boysen, Gunther
    Rodrigues, Daniel Nava
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa
    Miranda, Susana
    Figueiredo, Ines
    Aziz, Veronica Gil Sara
    Sharp, Adam
    Mehra, Niven
    Rescigno, Pasquale
    Mosquera, Juan M.
    Barbieri, Christopher E.
    Rubin, Mark A.
    de Bono, Johann S.
    CANCER RESEARCH, 2016, 76
12345